JP2022520862A5 - - Google Patents
Info
- Publication number
- JP2022520862A5 JP2022520862A5 JP2021548232A JP2021548232A JP2022520862A5 JP 2022520862 A5 JP2022520862 A5 JP 2022520862A5 JP 2021548232 A JP2021548232 A JP 2021548232A JP 2021548232 A JP2021548232 A JP 2021548232A JP 2022520862 A5 JP2022520862 A5 JP 2022520862A5
- Authority
- JP
- Japan
- Prior art keywords
- dao
- recombinant
- amino acid
- binding domain
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19157932.5 | 2019-02-19 | ||
| EP19157932 | 2019-02-19 | ||
| PCT/EP2020/054197 WO2020169577A1 (en) | 2019-02-19 | 2020-02-18 | New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520862A JP2022520862A (ja) | 2022-04-01 |
| JP2022520862A5 true JP2022520862A5 (enExample) | 2023-02-27 |
| JP7792252B2 JP7792252B2 (ja) | 2025-12-25 |
Family
ID=65493995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548232A Active JP7792252B2 (ja) | 2019-02-19 | 2020-02-18 | 新規組換えジアミンオキシダーゼおよび過剰ヒスタミンによって特徴づけられる疾患の治療のためのその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220145269A1 (enExample) |
| EP (1) | EP3927817B1 (enExample) |
| JP (1) | JP7792252B2 (enExample) |
| KR (1) | KR20210132650A (enExample) |
| CN (1) | CN113785052B (enExample) |
| AU (1) | AU2020225319B2 (enExample) |
| BR (1) | BR112021015865A2 (enExample) |
| CA (1) | CA3130751A1 (enExample) |
| EA (1) | EA202192305A1 (enExample) |
| ES (1) | ES3041133T3 (enExample) |
| IL (1) | IL285452B2 (enExample) |
| MX (1) | MX2021010050A (enExample) |
| SG (1) | SG11202107659SA (enExample) |
| WO (1) | WO2020169577A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
| WO2022072718A1 (en) | 2020-09-30 | 2022-04-07 | Nobell Foods, Inc. | Recombinant milk proteins and food compositions comprising the same |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| EP4496488A4 (en) * | 2022-03-21 | 2025-11-26 | Cedars Sinai Medical Center | METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE INTESTINAL MICROBIOME |
| IL317379A (en) * | 2022-06-03 | 2025-02-01 | Oyster Point Pharma Inc | AAV vector encoding diamine oxidase and its uses |
| EP4782002A1 (en) * | 2025-01-27 | 2026-07-29 | DR Healthcare S.L.U. | Diamine oxidase (dao) for use in the treatment of infertility |
| CN121975758B (zh) * | 2026-04-02 | 2026-07-14 | 华中科技大学同济医学院附属同济医院 | 组胺氧化酶蛋白及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK402785D0 (da) * | 1985-09-03 | 1985-09-03 | Syn Tek Ab | Fremgangsmaade til fremstilling af et enzym |
| US6075007A (en) * | 1997-07-17 | 2000-06-13 | Regeneron Pharmaceuticals, Inc. | Modified noggin polypeptide and compositions |
| IT1317067B1 (it) * | 2000-11-29 | 2003-05-26 | Univ Roma | Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| CA2536016C (en) * | 2002-08-16 | 2017-01-10 | Paul L. Deangelis | Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
| AT502098B8 (de) * | 2004-07-07 | 2007-06-15 | Albert Dr Missbichler | Diaminooxidase-hältige zusammensetzung |
| CA2660286A1 (en) * | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| WO2012028891A1 (en) * | 2010-09-02 | 2012-03-08 | Debreceni Egyetem | Perorally applicable preparation containing histaminase of vegetable origin, resistant to pepsin and trypsin and a process for producing it |
| JP2014518632A (ja) * | 2011-06-01 | 2014-08-07 | モアハウス スクール オブ メディスン | ケモカイン−免疫グロブリン融合ポリペプチド、組成物、その作製および使用の方法 |
| AU2015332533B2 (en) * | 2014-10-14 | 2018-08-30 | Halozyme, Inc. | Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same |
| WO2023122254A2 (en) * | 2021-12-22 | 2023-06-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods to elicit desire to mate and mating behavior |
-
2020
- 2020-02-18 JP JP2021548232A patent/JP7792252B2/ja active Active
- 2020-02-18 WO PCT/EP2020/054197 patent/WO2020169577A1/en not_active Ceased
- 2020-02-18 CA CA3130751A patent/CA3130751A1/en active Pending
- 2020-02-18 SG SG11202107659SA patent/SG11202107659SA/en unknown
- 2020-02-18 AU AU2020225319A patent/AU2020225319B2/en active Active
- 2020-02-18 BR BR112021015865-0A patent/BR112021015865A2/pt unknown
- 2020-02-18 CN CN202080020112.7A patent/CN113785052B/zh active Active
- 2020-02-18 EP EP20704547.7A patent/EP3927817B1/en active Active
- 2020-02-18 US US17/430,714 patent/US20220145269A1/en active Pending
- 2020-02-18 ES ES20704547T patent/ES3041133T3/es active Active
- 2020-02-18 MX MX2021010050A patent/MX2021010050A/es unknown
- 2020-02-18 EA EA202192305A patent/EA202192305A1/ru unknown
- 2020-02-18 IL IL285452A patent/IL285452B2/en unknown
- 2020-02-18 KR KR1020217024580A patent/KR20210132650A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takano et al. | Preference of calcium-dependent interactions between calmodulin-like domains of calpain and calpastatin subdomains | |
| US20190048046A1 (en) | Protein a mutants having high alkali resistance and methods of use thereof | |
| EP2288617B1 (en) | Polypeptide | |
| US20190177376A1 (en) | Novel alkaline stable immunoglobulin-binding proteins | |
| EP4493579A1 (en) | Vh3 binding polypeptides | |
| JP2021512085A (ja) | Ｃ末端螺旋領域にシステインを有するｆｃ結合タンパク質 | |
| CA3072288A1 (en) | Fc binding proteins with cysteine in the c-terminal helical region | |
| US20160280744A1 (en) | PROTEIN COMPRISED BY LINKING BY LINKER MULTIPLE DOMAINS HAVING AFFINTIY FOR PROTEINS HAVING Fc PART OF IMMUNOGLOBULIN G (IgG) | |
| CN106188251B (zh) | 一种免疫球蛋白结合蛋白突变体及其用途 | |
| CN102199586B (zh) | 一种肠病毒71型3c蛋白酶的结构及其应用 | |
| CN120923604B (zh) | 人白蛋白结合肽1e3及促进人白蛋白纯化的应用 | |
| CN114015708B (zh) | 一种深海细菌来源的α-葡萄糖苷酶QsGH13及其编码基因与应用 | |
| JP2024526356A5 (enExample) | ||
| CN116679071B (zh) | 免疫检测方法 | |
| CN1342771A (zh) | 结核分枝杆菌Ag85B抗原的表达纯化和作为疫苗组份的应用 | |
| CN115873834B (zh) | 一种溶葡萄球菌酶变体及其制备方法和应用 | |
| CN103275222B (zh) | 一种阻断白介素12 p40功能的单克隆抗体及其编码基因和应用 | |
| WO2023143525A1 (zh) | 蛋白a的b结构域和z结构域突变体及其应用 | |
| Roy et al. | Crystal structure of a fungal protease inhibitor from Antheraea mylitta | |
| Sun et al. | Evolution of the TCP gene family and pan-genome analysis in tea (Camellia sinensis) | |
| CN106084026B (zh) | 肿瘤血管内皮细胞标志物8突变体、其融合蛋白及应用 | |
| Wang et al. | Functional analysis of the α-neurotoxin, BmαTX14, derived from the Chinese scorpion, Buthus martensii Karsch | |
| CN106995484A (zh) | 一种利用定点突变和分子修饰技术改造的珍珠贝肉抗氧化肽及其构建和制备方法 | |
| JP2023545665A5 (enExample) | ||
| CN116334055A (zh) | 一种改造pl7家族褐藻胶裂解酶盐适应性的方法 |